Heart Disease in Women. (Record no. 59748)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07389nam a22004813i 4500 |
| 001 - CONTROL NUMBER | |
| control field | EBC3018565 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240729124104.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240724s2008 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781607410904 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781606920664 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (MiAaPQ)EBC3018565 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (Au-PeEL)EBL3018565 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (CaPaEBR)ebr10660426 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)839305400 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | MiAaPQ |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | MiAaPQ |
| Modifying agency | MiAaPQ |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC682 -- .H3836 2009eb |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.1/20082 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Lardner, Benjamin V. |
| 245 10 - TITLE STATEMENT | |
| Title | Heart Disease in Women. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | New York : |
| Name of producer, publisher, distributor, manufacturer | Nova Science Publishers, Incorporated, |
| Date of production, publication, distribution, manufacture, or copyright notice | 2008. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | ©2009. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (285 pages) |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro -- HEART DISEASE IN WOMEN -- Contents -- Preface -- Chapter I Cardiac Rehabilitation: Secondary Prevention of Cardiovascular Disease in Women -- Abstract -- Introduction -- Gender Differences in Cardiac Risk Factors -- Smoking -- Dyslipidemia -- Diabetes Mellitus -- Hypertension -- Obesity -- Depression -- Gender Differences in Diagnosis of Cardiovascular Disease -- Gender Differences in Prevention of Cardiovascular Disease -- Cardiac Rehabilitation Programs -- Gender Differences in Utilization of Cardiac Rehabilitation -- Gender Differences on Entry to a Cardiac Rehabilitation Program -- Gender Differences in Clinical Outcome in Cardiac Rehabilitation -- Morbidity and Mortality -- Diabetes Mellitus -- Lipids -- Obesity -- Depression -- Hypertension -- Conclusion -- References -- Chapter II Effects of Estrogen and its Receptors on Myocardial Infarction -- Abstract -- 1. Estrogen and Heart Failure Post-MI -- 1.1. Estrogen and Inflammation -- 1.2. Estrogen and Apoptosis -- 1.2.1. The Effect of Estrogen on Anti-Apoptosis System -- 1.2.2. The Effect of Estrogen on Apoptosis System -- 1.3. Estrogen and EPCs -- 1.4. Estrogen and Cardiac Hypertrophy -- 1.4.1. Role of ERs in Cadiocyte Hypertrophy -- 1.4.2. Anti-Hypertrophy Pathway Induced by Estrogen -- 2. Estrogen and Arrhythmia Post-MI -- 2.1. Estrogen and Neural Remodeling -- 2.2. Estrogen and Electrical Remodeling -- 2.2.1. Activating ATP-sensitive Potassium (KATP) Channels -- 2.2.2. Inhibiting Calcium Channels -- 2.2.3. Down-regulating Kv4.3 Expression -- 2.3. Estrogen and Structural Remodeling -- References -- Chapter III Preeclampsia and Risk of Cardiovascular Disease: Epidemiology and Pathophysiology -- Preeclampsia: Definition and Epidemiology -- Preeclampsia: Pathogenesis -- Preeclampsia and Cardiovascular Disease -- Inflammation as the Possible Link between CVD and PE. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | The Infectious Hypothesis -- Clinical and Research Implications -- References -- Chapter IV Diabetes and the Risk of Coronary Heart Disease among Women -- Abstract -- 1. Diabetes and Women's CHD Risk -- 2. The Magnitude of the Effect of Diabetes and Myocardial Infarction on Women's CHD Risk -- Conclusion -- References -- Chapter V The Impact of Heart Rate as a Cardiovascular Risk -- Abstract -- Introduction -- 1. Heart Rate as a Predictor of Risk for Cardiovascular Disorders: Epidemiologic Observations -- 2. Risk of Elevated Heart Rate on Cardiovascular Mortality in General Population -- Risk of Elevated Heart Rate for Hypertension and in the Elderly -- Recent Epidemiologic Data Relating Heart Rate and Outcome -- Gender Difference -- Heart Rate and Cardiovascular Risk Factors, Risk Stratification -- Pathophysiologic Mechanisms -- Heart Rate-Lowering Therapy -- Conclusion -- References -- Chapter VI Women in a World of Men's Disease: The Case of Female Cardiac Patients -- Abstract -- Introduction -- Gender Differences in the Response to Heart Disease -- Purpose of Study -- Design -- Sample -- Methods -- Analysis of Data -- Findings -- Discussion -- References -- Chapter VII Thromboembolism and Coronary Heart Disease: In Which Aspects are Women Different? -- Abstract -- Introduction -- Background -- Particularities of Anatomy, Physiology and Biomechanics in Women -- Pharmacogenetics, Pharmacokinetics and Pharmacodynamics of Cardiovascular Drugs in Women -- Influence of Estrogen on the Coagulation System -- Influence of Estrogen on the Endothelial Function -- Manifestatiosn of Thromboembolism and Arteriosclerosis -- Arterial Thromboembolism -- Therapeutic Consequences -- Anticoagulation -- Thrombolysis -- Screening before Oral Contraceptives -- Hormone Replacement Therapy (HRT) -- Betablockers -- ACE Inhibitors -- Conclusion. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Acknowledgments -- References -- Chapter VIII Aging Women and Coronary Heart Disease -- Abstract -- Abbreviations and Acronyms -- Introduction -- Epidemiology and Prognosis of CHD in Women -- Menopause -- Cardiovascular Risk Factors in Women -- Framingham Risk Score for Women -- Clinical Features (Clinical Manifestations) and Outcome -- Noninvasive Tests in the Diagnosis of CHD in Women -- Case Report 1. (EC 77 Years Old) -- Invasive Diagnostic Procedures (Coronary Angiography) -- Management of Coronary Heart Disease in Women -- Recommendations for Management of Cardiovascular Risk in Women -- Medical Treatment -- Case Report 2. (IK 78 Years Old) -- Hormone Replacement Therapy and CHD -- Case Report 3. (ZD 58 Years Old) -- Invasive Procedures -- Percutaneous Coronary Intervention -- Case Report 4. (DG 76 Years Old) -- Bypass Surgery -- Case Report 5. (ZG 81 Years Old) -- Pregnancy and CHD -- Conclusion -- References -- Chapter IX Prognosis of Women with Acute Coronary Syndromes: An Overview -- Abstract -- Introduction -- Definition and Clasification of Acute Coronary Syndromes (ACS) -- Epidemiology of ACS -- The Outcome and Prognosis of ACS in Women and Comparison to Men -- What Are the Reasons for Differences in Outcome between the Genders? -- Conclusions -- References -- Chapter X The Effects of Aging on the Electrophysiological Properties of the Atrial Myocardium in Women with and without Paroxysmal Atrial Fibrillation -- Abstract -- Introduction -- Material and Methods -- Study Patients -- Electrophysiologic Study -- Definitions -- Data Analysis -- Results -- The Influence of Age in Group I -- The Influence of Age in Group II -- Discussion -- Conclusions -- References -- Chapter XI Women and Angina Pectoris: Emergency Department and Diagnostic Difficulties in an Undeveloped Community -- Abstract -- Introduction. |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Methods and Results -- Discussion -- Conclusion -- References -- Index. |
| 588 ## - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Description based on publisher supplied metadata and other sources. |
| 590 ## - LOCAL NOTE (RLIN) | |
| Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heart diseases in women. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Internal medicine. |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pennelton, Harrison R. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Lardner, Benjamin V. |
| Title | Heart Disease in Women |
| Place, publisher, and date of publication | New York : Nova Science Publishers, Incorporated,c2008 |
| International Standard Book Number | 9781606920664 |
| 797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
| Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018565">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3018565</a> |
| Public note | Click to View |
No items available.